首页> Anticancer research> Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.

Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.

导出原文传递

翻译打印收藏纠错

第一作者： Hongjin,Chu

第一单位： The Central Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, P.R. China.

作者： Hongjin,Chu ^[1] ; Fengcai,Du ^[2] ; Zhaohua,Gong ^[3] ; Peiwen,Lian ^[1] ; Zhixin,Wang ^[1] ; Peng,Li ^[3] ; Baohong,Hu ^[3] ; Cheng,Chi ^[2] ; Jian,Chen ^[4]

作者单位： The Central Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, P.R. China. ^[1] The First Clinical College of DaLian Medical University, Dalian, P.R. China. ^[2] Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, P.R. China. ^[3] The Central Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, P.R. China chenjianyt@163.com.;Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, P.R. China. ^[4]

关键词 TIL Tumor-infiltrating lymphocytes ascites cisplatin malignant pleural effusion